Allergic Rhinitis

Asthma

Allergic Conjunctivitis

Atopic Dermatitis

Arnon Goldberg, M.D., Allergy and Clinical Immunology Unit, Meir Medical Center

The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel

Arnon Goldberg

Head, Allergy and Clinical Immunology Unit

Meir Medical Center

HIV Infections

Tuberculosis

Administration of lumefantrine 480mg co-formulated with artemether 80mg twice daily for three days to HIV positive patients receiving nevirapine 200mg twice daily as part of their antiretroviral treatment

Lumefantrine-artemether and nevirapine

Administration of lumefantrine 480mg co-formulated with artemether 80mg twice daily for three days to HIV positive adults receiving efavirenz tablets 600mg once daily

lumefantrine-artemether and efavirenz

Administration of lumefantrine 480mg co-formulated with artemether 80mg twice daily for three days to patients receiving rifampicin as part of fixed dose combination therapy for tuberculosis

Lumefantrine-artemether and rifampicin

Infectious Diseases Institute, Makerere University

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Pharmacokinetic Interaction Between Coartem® and Either Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Concepta Merry

Makerere University

Health Research Board, Ireland

Type I Hypersensitivity

Ragweed MATAMPL

Allied Research International Inc.

Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

Follow-up Study to Evaluate the Sustained Clinical Efficacy of Ragweed MATA MPL (Allergy Therapeutics®) in Patients With Ragweed-induced Seasonal Allergic Rhinitis Upon Re-exposure to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Model, Approximately One Year After Pre-seasonal Treatment in 2005

Allergy Therapeutics

Allergy

Rhinitis, Allergic, Seasonal

Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC)

Click here for the Immune Tolerance Network Web site

National Institute of Allergy and Infectious Diseases (NIAID)

Johns Hopkins University

Bernstein Clinical Research Center, University of Cincinnati

Optimed Research, Ohio State University

Pennsylvania State University

Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug

Asthma Immunotherapy With a Ragweed Allergen Immunostimulatory Sequence Conjugate

Immune Tolerance Network (ITN)

Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

A Double Blind Study to Investigate the Clinical Efficacy and Safety of Ragweed MATAMPL (Allergy Therapeutics®), Pollinex®-R (Allergy Therapeutics®) and Placebo in Patients With Seasonal Allergic Rhinitis With Ragweed Allergy, in an Environmental Exposure Chamber (EEC) Model, With Follow-Up During a Natural Ragweed Pollen Season